Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × entinostat × Clear all

NCT05053971 2026-03-18

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms